RJA
AEHR icon

Raymond James & Associates’s Aehr Test Systems AEHR Stock Holding History

Raymond James & Associates’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-28,782
Closed -$1.32M – 3829
2023
Q3 		$1.32M Sell
28,782
-1,278
-4% -$59.2K ﹤0.01% 2281
2023
Q2 		$1.24M Sell
30,060
-3,122
-9% -$102K ﹤0.01% 2350
2023
Q1 		$1.03M Sell
33,182
-9,377
-22% -$302K ﹤0.01% 2437
2022
Q4 		$855K Buy
+42,559
New +$910K ﹤0.01% 2527
2022
Q1 		– Sell
-8,600
Closed -$208K – 4114
2021
Q4 		$208K Buy
+8,600
New +$168K ﹤0.01% 3673

Other funds holding AEHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's AEHR Position: Q4 2023 in Review

Raymond James & Associates sold out of Aehr Test Systems (AEHR) in Q4 2023, closing a stake of 28,782 shares — an estimated $1.32M sold.

Raymond James & Associates first reported a position in AEHR in Q4 2021 and held it in 5 quarters. The position peaked at $1.32M in Q3 2023. 168 funds tracked by Wall St. Rank hold AEHR as of Q4 2023.

  • Raymond James & Associates reported no remaining Aehr Test Systems position as of Q4 2023 after selling out during the quarter.
  • Raymond James & Associates sold 28,782 Aehr Test Systems shares in Q4 2023, an estimated $1.32M.
  • Raymond James & Associates first reported a position in Aehr Test Systems in Q4 2021 and held it in 5 quarters.
  • Raymond James & Associates's Aehr Test Systems position peaked at $1.32M in Q3 2023.
  • 168 funds tracked by Wall St. Rank held Aehr Test Systems as of Q4 2023.

Based on Raymond James & Associates's 13F filing for Q4 2023, filed 16 Jan 2024.